A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients
Condition: Steroid Dependent Crohn's Disease Interventions: Drug: Cannabidiol , synthetic form; Drug: Placebo Sponsor: Stero Biotechs Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials